Lakatos B, Szabo BG, Bobek I, Kiss-Dala N, et al. Baricitinib versus tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: A prospective, investigational, real-world study. Int J Infect Dis 2022 Oct 31. pii: S1201-9712(22)00577.
PMID: 36328291